The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Bayer; BMSi; Eisai; Ipsen; Merck Serono; MSD
Consulting or Advisory Role - Bayer; BMSi; Eisai; Ipsen; Merck Serono
Research Funding - Merck Serono (Inst)
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche; Sanofi
 
Honoraria - Amgen; SERVIER
Molecular precision medicine in pancreatic cancer: A single-center experience.
 
Anthony Tarabay
No Relationships to Disclose
 
Antoine Hollebecque
Honoraria - Amgen; Eisai; SERVIER
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune (Inst); Debiopharm Group (Inst); Gritstone Bio; Incyte (Inst); Lilly (Inst); QED therapeutics; Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca/MedImmune; Incyte; Lilly; Roche; SERVIER
Other Relationship - Abbvie; Agios; Amgen; argenx; Arno Therapeutics; Astex Pharmaceuticals; AstraZeneca; AVEO; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Chugai Pharma; Clovis Oncology; Daiichi Sankyo; Debiopharm Group; Eisai; Exelixis; FORMA Therapeutics; GamaMabs Pharma; Genentech; GlaxoSmithKline; H3 Biomedicine; Innate Pharma; Janssen-Cilag; Kyowa Hakko Kirin; Lilly; Loxo; Lytix Biopharma; MedImmune; Menarini; Merck Sharp & Dohme; Merrimack; Merus; Millenium Pharamceuticals; Nanobiotix; Nektar; Novartis; Octimet; Oncoethix; Onyx; Orion; Oryzon Genomics; Pfizer; Pierre Fabre; Roche; Roche/Genentech; Sanofi/Aventis; SERVIER; Taiho Pharmaceutical; Tesaro; Xencor
 
Cristina Smolenschi
No Relationships to Disclose
 
Leony Antoun
No Relationships to Disclose
 
Caroline Klotz
No Relationships to Disclose
 
Alina Fuerea
No Relationships to Disclose
 
Audrey Perret
No Relationships to Disclose
 
Claire Gouriou
No Relationships to Disclose
 
Pascal Burtin
No Relationships to Disclose
 
Hichem Belkhodja
No Relationships to Disclose
 
Valérie Boige
No Relationships to Disclose
 
David Malka
Honoraria - Agios; Amgen; Bayer; Bristol Myers Squibb; Incyte; LEO Pharma; Merck Serono; MSD Oncology; Pierre Fabre; Roche; Sanofi; SERVIER; Viatris
Consulting or Advisory Role - Agios; Amgen; Bayer; Bristol Myers Squib; Incyte; Merck Serono; MSD; Roche; Sanofi; SERVIER
Travel, Accommodations, Expenses - Amgen; Bayer; Merck Serono; Roche; Sanofi; Servier
 
Michel Ducreux
Employment - Sandoz (I)
Honoraria - Amgen; Bayer; Celgene; Ipsen; Lilly; Merck Serono; MSD Oncology; Novartis; Roche/Genentech; Servier
Consulting or Advisory Role - Amgen; Celgene; HalioDx; Ipsen; Lilly; Merck Serono; Novartis; Pierre Fabre; Roche; Servier
Speakers' Bureau - Bayer; Celgene; Ipsen; Merck KGaA; Roche
Research Funding - Keocyt (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Ipsen; Merck Serono; Roche